Physician profile
Danny Danziger
NPI 1649272089
$1,594.13
in general payments reported to CMS, 2019-2025
17 companies · $211 in 2025
The $211 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $142 · 2022: $205 · 2023: $21.41 · 2024: $376 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $380.63 | 2019-2022 | |
| Tris Pharma INC | $282.61 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $160.80 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $125.00 | 2024 | Daybue |
| Organon LLC | $124.40 | 2025 | Vtama |
| Supernus Pharmaceuticals, INC. | $112.56 | 2024-2025 | Qelbree |
| Corium, LLC | $75.30 | 2022-2024 | Azstarys |
| Sanofi-Aventis U.S. LLC | $65.71 | 2024-2025 | |
| Pfizer INC. | $64.78 | 2023-2025 | |
| Kaleo, INC. | $51.22 | 2022-2024 | Auvi-Q |
| Cranial Technologies, INC | $41.53 | 2019-2024 | Doc Band |
| Shire North American Group INC | $28.44 | 2019 | |
| Cipher Pharmaceuticals US LLC | $21.08 | 2025 | Spinosad, Natroba |
| Glaxosmithkline, LLC. | $17.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.77 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.68 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Danziger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.